Dr. Mohamad Ali Hijazi received his B.S. degree in Pharmacy from Beirut Arab University in 2007 with high distinction and honors. In recognition of his academic excellence, he was awarded scholarships to pursue his graduate studies at BAU, where he obtained his master’s and Ph.D. degrees in Pharmaceutical Sciences. He joined the Faculty of Pharmacy as a Lecturer in 2014, was promoted to Assistant Professor in 2017 and subsequently to Associate Professor and currently serves as Assistant Dean of the Faculty.

Dr. Hijazi has developed a multidisciplinary academic profile integrating pharmaceutical sciences, pharmacy education, professional practice, public health, and health policy. Drawing on experience across community pharmacy, the pharmaceutical industry, academia, and research, he views education, research, professional practice, community engagement, and policy as an integrated cycle of impact.

As a mixed-methods researcher, his interests span natural products and drug discovery, phytochemical and biological evaluation, complementary and alternative medicine, pharmacy practice, public health, and digital health. His research emphasizes translating scientific evidence into professional practice, educational innovation, community interventions, and evidence-informed health policies to generate knowledge that serves society and strengthens healthcare systems.

Hijazi MA. A Pharmaceutical Preparation from Lebanese Plant Extract as Potential Natural Opioid Analgesic and Remedy for Treatment of Opioid Dependence. Filled as: Lebanon Patent (Application No. 11070, issued on 6/12/2016)

His research identity is rooted in Natural Product Drug Discovery, which represents his success in research and innovation. Coupled to his research arm in evidence-based practices, he extended his work into epidemiological studies to ensure safe, effective, and responsible application. In addition to his strong arm in service to stakeholders and policy makers to ensure the proper translation of research findings into meaningful health policy, guidelines, and community services. In this way, he finds both purpose and impact.

Peer reviewed apers:

• Chouman A, Aboul Ela M, Bouhadir K, Azakir B, El-Lakany A, Hijazi MA (2026). “Anticancer Potential and Phytochemical Constituents of Ononis natrix Grown in Lebanon”. Journal of Applied Pharmaceutical Science. 2026.
• Kanso M, Hijazi MA, Ellakany A, and Aboul-Ela M, (2026). “Alkamides in Asteraceae Family: Bioactivity and Structural Relationships”. Current Bioactive Compounds, 
• Abdelmajid G, Ellakany A, Aboul-Ela M, Hijazi S, A, and Hijazi MA* (2026). “Phytochemical and Antibacterial Study of Juniperus chinensis and Juniperus conferta Growing in Lebanon”. Current Bioactive Compounds, 
• El Shamieh S, Abdel Jabbar M, Fakhoury R, Aljada A, Anouti N, Kreidieh D, Hassan D, Hijazi MA and Fakhoury HMA (2026). “Vitamin D status and Helicobacter pylori infection: clinical associations and lipid pathway differences in an exploratory metabolomics sub-study”. Front. Nutr. 13:1812874.
• Hijazi MA* (2026). “Digital Transformation of Healthcare in Lebanon: A Strategic Response to Health System Fragility”. Int J Health Policy Manag, 2026;15:9482. 
• Kanso M, Hijazi S., Ellakany A, Aboul-Ela M, and Hijazi MA* (2026). “Phytochemical Investigation and Antimicrobial Activity of Galium libanoticum”. Infectious Disorders - Drug Targets, 26(2), e18715265398196. 
• Naja F, Ahmad M, Shatila H, Abu Shihab K, Naalbandian S, Saqan R, Alzubaidi H, and Hijazi MA* (2025). “Role of community pharmacists in the safe and effective use of complementary and alternative medicine in the Middle East: A scoping review”. PLOS ONE, 20(9). 
• Chouman A., Ellakany A, Aboul-Ela M, and Hijazi MA*, (2025). “Review on phenolic constituents and pharmacological activities of genus Ononis”. Journal of Applied Pharmaceutical Sciences, Vol. 15(07), pp 027-036. 
• Kanso M, Hijazi MA, Ellakany A, and Aboul-Ela M (2024). “Review on phytochemical constituents and pharmacological activities of genus Galium”. Journal of Applied Pharmaceutical Sciences, Vol. 14(09), pp 046-056. 
• Hijazi MA, Gessner A., Abu Qiyas S, and El-Najjar N (2023). “Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp”. Cancers, 15(12): 3199,
• Hijazi MA, Shatila H, Abu Qiyas S, Aboul-Ela M Ellakany A, and Naja F (2022). Complementary and alternative medicine use during the COVID-19 pandemic: Community pharmacists’ knowledge, attitudes, and practices”. Research in Social and Administrative Pharmacy, vol. 19,3 (2023): 502-509. 
• Alameddine M, Bou Karroum K, and Hijazi MA* (2022). “A national study on the resilience of community pharmacists in Lebanon: a cross-sectional survey”. Journal of Pharmaceutical Policy and Practice, 15(8),
• Hijazi MA*, Hijazi K, Bouhadir K, Fatfat Z, Aboul-Ela M, Gali-Muhtasib H, and Ellakany A (2021). “Anticancer Activity of Abietane Diterpenoids from Salvia libanoticum Grown in Lebanon”. Pharmacognosy Magazine, 17 (73), 127-133
• Hijazi MA, Shatila H, Ellakany A, Aboul-Ela M, and Naja F (2021). “The role of pharmacists in complementary and alternative medicine in Lebanon: user’s perspectives”. BMC Complementary Medicine & Therapies, 21, 81 (2021). 
• Alameddine M, Bou Karroum K, Kassas S, and Hijazi MA* (2020). “A profession in danger: Stakeholders’ perspectives on supporting the pharmacy profession in Lebanon”. PLOS ONE, 15(11), e0242213.
• Hijazi MA, Shatila H, Ellakany A, Rifai H, Aboul-Ela M, and Naja F (2020). “Role of community pharmacists in weight management: results of a national study in Lebanon”. BMC Health Services Research, 20, 386 (2020). 
• Alameddine M, Bou Karroum K, and Hijazi MA* (2019). “Upscaling the pharmacy profession in Lebanon: workforce distribution and key improvement opportunities”. Human Resources for Health, 17(47), 1-9. 
• Hijazi MA, Shatila H, Ellakany A, Aboul-Ela M, Kharoubi S, Alameddine M, and Naja F (2019). “Beliefs, practices and knowledge of community pharmacists regarding complementary and alternative medicine: national cross-sectional study in Lebanon”. BMJ Open, 9(3), 1-10. 2019;9:e025074. 
• Kassem I, Hijazi MA, and Saab R (2019). “The availability and use of colistin-containing drugs in human therapeutics and food-animal farming in Lebanon”. Journal of Global Antimicrobial Resistance, 16(2019): 162-164. 
• Hijazi MA*, Aboul-Ela M, Bouhadir K, Fatfat M,  Gali-Muhtasib H, and Ellakany A (2018). “Alkaloids of Papaver libanoticum and their Cytotoxic”. Records of Natural Products, 12(6): 611-618. 
• Hijazi MA*, Elmallah A, Aboul-Ela M, and Ellakany A (2017). “Evaluation of Analgesic Activity of Papaver libanoticum Extract in Mice: Involvement of Opioids Receptors”. Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 8935085, 13 pages, 
• Hijazi MA*, Aboul-Ela M, Bouhadir K, Fatfat M, Khalife H, Ellakany A, and Gali-Muhtasib H (2017). “Cytotoxic Activity of Alkaloids from Papaver rhoeas growing in Lebanon”. Records of Natural Products, 11(2), 211-216.